Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 3 3Phase 2 2Phase 1/2 2Phase 2/3 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other 1

Conditions

Polycystic Ovary Syndrome 3Overweight 1Obesity 1

Interventions

Dexamethasone 49Metformin 47Cyclophosphamide 42Saline Solution 38Cytarabine 34Sodium Chloride 32Bupivacaine 31Vincristine 27Cisplatin 26Propofol 25Methotrexate 25Letrozole 24Fluorouracil 24Dexmedetomidine 24Doxorubicin 23Fentanyl 22Carboplatin 22Etoposide 19Rituximab 18Morphine 18Bevacizumab 18Acetaminophen 18Lidocaine 17Granulocyte Colony-Stimulating Factor 17Prednisone 16Mercaptopurine 16Docetaxel 16Clomiphene 16Sevoflurane 15Ropivacaine 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × OTHER × Exenatide × Clear all
NCT04969627 2022-04-14

Effects of GLP-1 Analogue Combined With Metformin and Metformin on Gonadal and Metabolic Profiles in Chinese Overweight/Obese PCOS Patients With Hyperandrogenemia.

Shengjing Hospital

Phase 4 Completed
60 enrolled

Polycystic Ovary Syndrome

NCT03352869 2019-09-11

Research of Exenatide for Overweight/Obese PCOS Patients With IGR

RenJi Hospital

Phase 4 Completed
183 enrolled
Other

Obesity, Polycystic Ovary Syndrome, Overweight

NCT04029272 2019-07-23

Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients

Peking Union Medical College Hospital

Phase 4 Unknown
80 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡